Comparison of the selective aromatase inhibitor formestane with tamoxifen as first-line hormonal therapy in postmenopausal women with advanced breast cancer.
Year: 1994
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: PubMed
Institution: Hospital Universitario de La Princesa
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W42023183
